The SDF-1-CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis

Trends in Immunology

Volumn 28, Issue 7, 2007, Pages 299-307

  Petit, Isabelle ^a   Jin, David ^a   Rafii, Shahin ^a  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,1' [1,4 PHENYLENEBIS(METHYLENE)]BIS(1,4,8,11 TETRAAZACYCLOTETRADECANE); CHEMOKINE RECEPTOR CXCR4 AGONIST; CHEMOKINE RECEPTOR CXCR4 ANTAGONIST; CHEMOKINE RECEPTOR CXCR6; STROMAL CELL DERIVED FACTOR 1; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE MARROW CELL; BRAIN ISCHEMIA; CELL FUNCTION; CELL MIGRATION; CELL MOTILITY; CYTOKINE RELEASE; DRUG INHIBITION; HEART INFARCTION; HEMATOPOIETIC CELL; HUMAN; ISCHEMIA; NONHUMAN; PROTEIN EXPRESSION; REVASCULARIZATION; STEM CELL; STEM CELL TRANSPLANTATION; TISSUE INJURY; TUMOR GROWTH; VASCULARIZATION;

ANIMALS; ANOXIA; BONE MARROW; CELL MOVEMENT; CHEMOKINES, CXC; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; SIGNAL TRANSDUCTION;

EID: 34250724520     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.it.2007.05.007     Document Type: Article

References (82)

1. Asahara T., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275 (1997) 964-967
2. Aicher A., et al. Nonbone marrow-derived circulating progenitor cells contribute to postnatal neovascularization following tissue ischemia. Circ. Res. 100 (2007) 581-589
3. De Palma M., and Naldini L. Role of haematopoietic cells and endothelial progenitors in tumour angiogenesis. Biochim. Biophys. Acta 1766 (2006) 159-166
4. Bertolini F., et al. The multifaceted circulating endothelial cell in cancer: towards marker and target identification. Nat. Rev. Cancer 6 (2006) 835-845
5. Lyden D., et al. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat. Med. 7 (2001) 1194-1201
6. Rafii S., et al. Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy?. Nat. Rev. Cancer 2 (2002) 826-835
7. Ratajczak M.Z., et al. The pleiotropic effects of the SDF-1-CXCR4 axis in organogenesis, regeneration and tumorigenesis. Leukemia 20 (2006) 1915-1924
8. Ara T., et al. The role of CXCL12 in the organ-specific process of artery formation. Blood 105 (2005) 3155-3161
9. + stem cell recruitment to the liver. J. Clin. Invest. 112 (2003) 160-169
10. Shiba Y., et al. M-CSF accelerates neointimal formation in the early phase after vascular injury in mice: the critical role of the SDF-1-CXCR4 system. Arterioscler. Thromb. Vasc. Biol. 27 (2007) 283-289
11. Ponomaryov T., et al. Induction of the chemokine stromal-derived factor-1 following DNA damage improves human stem cell function. J. Clin. Invest. 106 (2000) 1331-1339
12. Ceradini D.J., et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat. Med. 10 (2004) 858-864
13. Lee S.P., et al. Integrin-linked kinase, a hypoxia-responsive molecule, controls postnatal vasculogenesis by recruitment of endothelial progenitor cells to ischemic tissue. Circulation 114 (2006) 150-159
14. Askari A.T., et al. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 362 (2003) 697-703
15. Wang Y., et al. Evidence for ischemia induced host-derived bone marrow cell mobilization into cardiac allografts. J. Mol. Cell. Cardiol. 41 (2006) 478-487
16. Pillarisetti K., and Gupta S.K. Cloning and relative expression analysis of rat stromal cell derived factor-1 (SDF-1)1: SDF-1 α mRNA is selectively induced in rat model of myocardial infarction. Inflammation 25 (2001) 293-300
17. Ma J., et al. Time course of myocardial stromal cell-derived factor 1 expression and beneficial effects of intravenously administered bone marrow stem cells in rats with experimental myocardial infarction. Basic Res. Cardiol. 100 (2005) 217-223
18. De Falco E., et al. SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells. Blood 104 (2004) 3472-3482
19. + cell-derived endothelial progenitor cell transplantation. Thromb. Haemost. 91 (2004) 1202-1212
20. + hemangiocytes. Nat. Med. 12 (2006) 557-567
21. Grunewald M., et al. VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell 124 (2006) 175-189
22. Schober A., et al. Crucial role of stromal cell-derived factor-1α in neointima formation after vascular injury in apolipoprotein E-deficient mice. Circulation 108 (2003) 2491-2497
23. Urbich C., et al. Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. J. Mol. Cell. Cardiol. 39 (2005) 733-742
24. Kryczek I., et al. Stromal derived factor (SDF-1/CXCL12) and human tumor pathogenesis. Am J Physiol Cell Physiol 292 (2006) C987-C995
25. Orimo A., et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121 (2005) 335-348
26. Ohira S., et al. Possible regulation of migration of intrahepatic cholangiocarcinoma cells by interaction of CXCR4 expressed in carcinoma cells with tumor necrosis factor-α and stromal-derived factor-1 released in stroma. Am. J. Pathol. 168 (2006) 1155-1168
27. Rubin J.B., et al. A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 13513-13518
28. Salvucci O., et al. Regulation of endothelial cell branching morphogenesis by endogenous chemokine stromal-derived factor-1. Blood 99 (2002) 2703-2711
29. Hiasa K., et al. Gene transfer of stromal cell-derived factor-1α enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularization. Circulation 109 (2004) 2454-2461
30. Yamaguchi J., et al. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 107 (2003) 1322-1328
31. Hattori K., et al. Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells. Blood 97 (2001) 3354-3360
32. Heissig B., et al. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 109 (2002) 625-637
33. Togel F., et al. Renal SDF-1 signals mobilization and homing of CXCR4-positive cells to the kidney after ischemic injury. Kidney Int. 67 (2005) 1772-1784
34. Massberg S., et al. Platelets secrete stromal cell-derived factor 1α and recruit bone marrow-derived progenitor cells to arterial thrombi in vivo. J. Exp. Med. 203 (2006) 1221-1233
35. Stellos K., and Gawaz M. Platelets and stromal cell-derived factor-1 in progenitor cell recruitment. Semin. Thromb. Hemost. 33 (2007) 159-164
36. Dar A., et al. Chemokine receptor CXCR4-dependent internalization and resecretion of functional chemokine SDF-1 by bone marrow endothelial and stromal cells. Nat. Immunol. 6 (2005) 1038-1046
37. Aicher A., et al. Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat. Med. 9 (2003) 1370-1376
38. Sbaa E., et al. Caveolin plays a central role in endothelial progenitor cell mobilization and homing in SDF-1-driven postischemic vasculogenesis. Circ. Res. 98 (2006) 1219-1227
39. Urbich C., et al. Cathepsin L is required for endothelial progenitor cell-induced neovascularization. Nat. Med. 11 (2005) 206-213
40. Kollet O., et al. Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells. Nat. Med. 12 (2006) 657-664
41. Reca R., et al. Functional receptor for C3a anaphylatoxin is expressed by normal hematopoietic stem/progenitor cells, and C3a enhances their homing-related responses to SDF-1. Blood 101 (2003) 3784-3793
42. + stem/progenitor cells to bone marrow. Blood 103 (2004) 2981-2989
43. Wysoczynski M., et al. Incorporation of CXCR4 into membrane lipid rafts primes homing-related responses of hematopoietic stem/progenitor cells to an SDF-1 gradient. Blood 105 (2005) 40-48
44. Capoccia B.J., et al. G-CSF and AMD3100 mobilize monocytes into the blood that stimulate angiogenesis in vivo through a paracrine mechanism. Blood 108 (2006) 2438-2445
45. Shepherd R.M., et al. Angiogenic cells can be rapidly mobilized and efficiently harvested from the blood following treatment with AMD3100. Blood 108 (2006) 3662-3667
46. Petit I., et al. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat. Immunol. 3 (2002) 687-694
47. Levesque J.P., et al. Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide. J. Clin. Invest. 111 (2003) 187-196
48. Semerad C.L., et al. G-CSF potently inhibits osteoblast activity and CXCL12 mRNA expression in the bone marrow. Blood 106 (2005) 3020-3027
49. Zhong R., et al. Small peptide analogs to stromal derived factor-1 enhance chemotactic migration of human and mouse hematopoietic cells. Exp. Hematol. 32 (2004) 470-475
50. Vajkoczy P., et al. Multistep nature of microvascular recruitment of ex vivo-expanded embryonic endothelial progenitor cells during tumor angiogenesis. J. Exp. Med. 197 (2003) 1755-1765
51. Yao L., et al. Selective expression of stromal-derived factor-1 in the capillary vascular endothelium plays a role in Kaposi sarcoma pathogenesis. Blood 102 (2003) 3900-3905
52. Butler J.M., et al. SDF-1 is both necessary and sufficient to promote proliferative retinopathy. J. Clin. Invest. 115 (2005) 86-93
53. Chavakis E., et al. Role of β2-integrins for homing and neovascularization capacity of endothelial progenitor cells. J. Exp. Med. 201 (2005) 63-72
54. Wu Y., et al. Essential role of ICAM-1/CD18 in mediating EPC recruitment, angiogenesis, and repair to the infarcted myocardium. Circ. Res. 99 (2006) 315-322
55. Duan H., et al. LFA-1 and VLA-4 involved in human high proliferative potential-endothelial progenitor cells homing to ischemic tissue. Thromb. Haemost. 96 (2006) 807-815
56. Kryczek I., et al. CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers. Cancer Res. 65 (2005) 465-472
57. Carr A.N., et al. Efficacy of systemic administration of SDF-1 in a model of vascular insufficiency: support for an endothelium-dependent mechanism. Cardiovasc. Res. 69 (2006) 925-935
58. Aghi M., et al. Tumor stromal-derived factor-1 recruits vascular progenitors to mitotic neovasculature, where microenvironment influences their differentiated phenotypes. Cancer Res. 66 (2006) 9054-9064
59. Wang J., et al. Diverse signaling pathways through the SDF-1/CXCR4 chemokine axis in prostate cancer cell lines leads to altered patterns of cytokine secretion and angiogenesis. Cell. Signal. 17 (2005) 1578-1592
60. Wang J., et al. A glycolytic mechanism regulating an angiogenic switch in prostate cancer. Cancer Res. 67 (2007) 149-159
61. Heissig B., et al. Angiogenesis: vascular remodeling of the extracellular matrix involves metalloproteinases. Curr. Opin. Hematol. 10 (2003) 136-141
62. + progenitor cells. J. Clin. Invest. 115 (2005) 168-176
63. Smith M.C., et al. CXCR4 regulates growth of both primary and metastatic breast cancer. Cancer Res. 64 (2004) 8604-8612
64. Zernecke A., et al. SDF-1alpha/CXCR4 axis is instrumental in neointimal hyperplasia and recruitment of smooth muscle progenitor cells. Circ. Res. 96 (2005) 784-791
65. Lamagna C., and Bergers G. The bone marrow constitutes a reservoir of pericyte progenitors. J. Leukoc. Biol. 80 (2006) 677-681
66. Balabanian K., et al. The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes. J. Biol. Chem. 280 (2005) 35760-35766
67. Burns J.M., et al. A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. J. Exp. Med. 203 (2006) 2201-2213
68. Madden S.L., et al. Vascular gene expression in nonneoplastic and malignant brain. Am. J. Pathol. 165 (2004) 601-608
69. Hatse S., et al. Stromal cell-derived factor 1 (CXCL12) binds to endothelial cells and signals through a receptor different from CXCR4. Biochem. Biophys. Res. Commun. 348 (2006) 192-199
70. De Clercq E. Potential clinical applications of the CXCR4 antagonist bicyclam AMD3100. Mini Rev. Med. Chem. 5 (2005) 805-824
71. Tsutsumi H., et al. The therapeutic potential of the chemokine receptor CXCR4 antagonists as multi-functional agents. Biopolymers 88 (2006) 279-289
72. Redjal N., et al. CXCR4 inhibition synergizes with cytotoxic chemotherapy in gliomas. Clin. Cancer Res. 12 (2006) 6765-6771
73. Stamm C., et al. Stem cell therapy for ischemic heart disease: beginning or end of the road?. Cell Transplant. 15 Suppl. 1 (2006) S47-S56
74. Koch K.C., et al. Effect of catheter-based transendocardial delivery of stromal cell-derived factor 1α on left ventricular function and perfusion in a porcine model of myocardial infarction. Basic Res. Cardiol. 101 (2006) 69-77
75. Ohki Y., et al. Granulocyte colony-stimulating factor promotes neovascularization by releasing vascular endothelial growth factor from neutrophils. FASEB J. 19 (2005) 2005-2007
76. Korbling M., et al. Recombinant human granulocyte-colony-stimulating factor-mobilized and apheresis-collected endothelial progenitor cells: a novel blood cell component for therapeutic vasculogenesis. Transfusion 46 (2006) 1795-1802
77. + cells in post-infarct cardiac repair mediated by G-CSF. Cardiovasc. Res. 71 (2006) 455-465
78. Kovacic J.C., et al. Actions and therapeutic potential of G-CSF and GM-CSF in cardiovascular disease. J. Mol. Cell. Cardiol. 42 (2007) 19-33
79. Luyt C.E., et al. Low-molecular-weight fucoidan promotes therapeutic revascularization in a rat model of critical hindlimb ischemia. J. Pharmacol. Exp. Ther. 305 (2003) 24-30
80. Walter D.H., et al. Sphingosine-1-phosphate stimulates the functional capacity of progenitor cells by activation of the CXCR4-dependent signaling pathway via the S1P3 receptor. Arterioscler. Thromb. Vasc. Biol. 27 (2007) 275-282
81. + stem cells. Exp. Hematol. 34 (2006) 986-995
82. Schober A., et al. SDF-1α-mediated tissue repair by stem cells: a promising tool in cardiovascular medicine?. Trends Cardiovasc. Med. 16 (2006) 103-108